Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
urology (80) 80
humans (25) 25
bladder cancer (22) 22
index medicus (19) 19
male (17) 17
urology & nephrology (16) 16
female (14) 14
cancer (13) 13
cystectomy (13) 13
middle aged (13) 13
urinary bladder neoplasms - pathology (12) 12
adult (10) 10
aged (10) 10
chemotherapy (10) 10
aged, 80 and over (8) 8
diagnosis (8) 8
eau guidelines (7) 7
neoplasm staging (7) 7
oncology (7) 7
quality of life (7) 7
radical cystectomy (7) 7
neoplasm invasiveness (6) 6
surgery (6) 6
carcinoma, transitional cell - pathology (5) 5
gene expression (5) 5
metastasis (5) 5
prognosis (5) 5
prostate cancer (5) 5
research (5) 5
transitional-cell carcinoma (5) 5
treatment outcome (5) 5
urinary bladder neoplasms - genetics (5) 5
urinary bladder neoplasms - therapy (5) 5
urinary diversion (5) 5
carcinoma (4) 4
disease progression (4) 4
further section (4) 4
genetic aspects (4) 4
multidisciplinary management (4) 4
muscle invasive bladder cancer (4) 4
muscle-invasive (4) 4
prognostic-factors (4) 4
quimioterapia (4) 4
radiation therapy (4) 4
retrospective studies (4) 4
risk factors (4) 4
sensitivity and specificity (4) 4
surgical technique (4) 4
twitter (4) 4
urinary bladder neoplasms - diagnosis (4) 4
urothelial carcinoma (4) 4
analysis (3) 3
bacillus-calmette-guerin (3) 3
calidad de vida (3) 3
carcinoma, transitional cell - genetics (3) 3
cistectomía (3) 3
clinical medicine (3) 3
cystectomy - methods (3) 3
cystoscopy (3) 3
cytology (3) 3
follow-up (3) 3
guideline (3) 3
guidelines (3) 3
hematology, oncology and palliative medicine (3) 3
immunology (3) 3
incidence (3) 3
internal medicine (3) 3
klinisk medicin (3) 3
less (3) 3
living donor nephrectomy (3) 3
lymph-node dissection (3) 3
medical and health sciences (3) 3
medical colleges (3) 3
medicin och hälsovetenskap (3) 3
neoplasm metastasis (3) 3
oncology, experimental (3) 3
partial nephrectomy (3) 3
phase-iii trial (3) 3
predictive value of tests (3) 3
prospective studies (3) 3
prostatic neoplasms - pathology (3) 3
quality-of-life (3) 3
radiotherapy (3) 3
social networks (3) 3
spain (3) 3
transitional-cell-carcinoma (3) 3
transplantation (3) 3
urinary bladder neoplasms (3) 3
urinary bladder neoplasms - surgery (3) 3
@infoaeu (2) 2
@residentesaeu (2) 2
@uroweb (2) 2
aberrations (2) 2
allelic loss (2) 2
androgens (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bcg (2) 2
biomarkers (2) 2
biomarkers - blood (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
by Witjes, J. Alfred and Compérat, Eva and Cowan, Nigel C and De Santis, Maria and Gakis, Georgios and Lebret, Thierry and Ribal, Maria J and Van der Heijden, Antoine G and Sherif, Amir and European Association of Urology and Medicinska fakulteten and Urologi och andrologi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 4, pp. 778 - 792
Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-invasive and Metastatic bladder cancer (BCa) updates its guidelines... 
Urology | EAU guidelines | Cystectomy | Chemotherapy | Bladder sparing treatments | Comorbidities | Cisplatin-based | Infiltrative | Bladder cancer | Invasive | Quality of life | LYMPH-NODE DISSECTION | BACILLUS-CALMETTE-GUERIN | UROTHELIAL CARCINOMA | LONG-TERM-SURVIVAL | CISPLATIN-BASED CHEMOTHERAPY | PHASE-III TRIAL | TRANSITIONAL-CELL-CARCINOMA | RADICAL CYSTECTOMY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | ELDERLY-PATIENTS | Muscle Neoplasms - diagnosis | Muscle Neoplasms - therapy | Neoplasm Metastasis | Neoplasm Invasiveness | Urinary Bladder Neoplasms - diagnosis | Humans | Muscle Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Combined Modality Therapy | Neoplasm Staging | Cystectomy - methods | Metastasis | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
by Alfred Witjes, J and Lebret, Thierry and Compérat, Eva M and Cowan, Nigel C and De Santis, Maria and Bruins, Harman Maxim and Hernández, Virginia and Espinós, Estefania Linares and Dunn, James and Rouanne, Mathieu and Neuzillet, Yann and Veskimäe, Erik and van der Heijden, Antoine G and Gakis, Georgios and Ribal, Maria J
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 462 - 475
Abstract Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate despite optimal treatment. The European Association of... 
Urology | Cystectomy | Treatment | Multimodality | EAU | Metastatic | Muscle invasive | Diagnosis | Bladder cancer | Follow-up | Guidelines | LYMPH-NODE DISSECTION | BACILLUS-CALMETTE-GUERIN | UROTHELIAL CARCINOMA | INTENSITY-MODULATED RADIOTHERAPY | PHASE-III TRIAL | URINARY-DIVERSION | TRANSITIONAL-CELL CARCINOMA | RADICAL CYSTECTOMY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | RECURRENCE-FREE SURVIVAL | Neoplasm Invasiveness | Europe | Humans | Carcinoma, Transitional Cell - secondary | Cystoscopy | Carcinoma, Transitional Cell - therapy | Urinary Bladder - pathology | Radiotherapy | Neoplasm Metastasis | Societies, Medical | Carcinoma, Transitional Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | BCG Vaccine - therapeutic use | Adjuvants, Immunologic - therapeutic use | Muscle, Smooth - pathology | Mortality | Metastasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
by Stenzl, Arnulf and Cowan, Nigel C and De Santis, Maria and Kuczyk, Markus A and Merseburger, Axel S and Ribal, Maria José and Sherif, Amir and Witjes, J. Alfred and European Association of Urology (EAU)
European Urology, ISSN 0302-2838, 2011, Volume 59, Issue 6, pp. 1009 - 1018
Abstract Context New data regarding treatment of muscle-invasive and metastatic bladder cancer (MiM-BC) has emerged and led to an update of the European... 
Urology | Multidisciplinary management | Chemotherapy | Cystectomy | EAU guidelines | Muscle-invasive | Radiation therapy | Bladder cancer | Quality of life | PROGNOSTIC-FACTORS | UROTHELIAL CARCINOMA | LONG-TERM-SURVIVAL | ASSISTED RADICAL CYSTECTOMY | PHASE-III TRIAL | SURGICAL COMPLICATIONS | ORTHOTOPIC NEOBLADDER | TRANSITIONAL-CELL-CARCINOMA | NEOADJUVANT CHEMOTHERAPY | PROSTATE-CANCER | UROLOGY & NEPHROLOGY | Urinary Bladder Neoplasms - diagnosis | Humans | Male | Antineoplastic Agents - administration & dosage | Vinblastine - administration & dosage | Cystectomy - adverse effects | Cisplatin - administration & dosage | Patient Selection | Time Factors | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Urinary Diversion - adverse effects | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Risk Assessment | Neoplasm Invasiveness | Risk Factors | Neoplasm Recurrence, Local | Treatment Outcome | Urinary Bladder Neoplasms - secondary | Evidence-Based Medicine | Disease-Free Survival | Urinary Bladder Neoplasms - therapy | Medical colleges | Care and treatment | Radiation | Metastasis | Radiotherapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
by Stenzl, Arnulf and Cowan, Nigel C and De Santis, Maria and Jakse, Gerhard and Kuczyk, Marcus A and Merseburger, Axel S and Ribal, Maria José and Sherif, Amir and Witjes, J. Alfred
European Urology, ISSN 0302-2838, 2009, Volume 55, Issue 4, pp. 815 - 825
Abstract Context New data regarding diagnosis and treatment of muscle-invasive and metastatic bladder cancer (MiM-BC) has emerged and led to an update of the... 
Urology | Chemotherapy | Cystectomy | Urinary diversion | Muscle invasive bladder cancer | Bladder neoplasms | Guidelines | Neoplasm Metastasis | Neoplasm Invasiveness | Urinary Bladder Neoplasms - diagnosis | Humans | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Female | Male | Neoplasm Staging | Practice Guidelines as Topic | Medical colleges | Metastasis | Bladder cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text 814PLonger time from diagnosis to docetaxel treatment results in a shorter survival in metastatic hormonosensitive prostate cancer (mHSPC) patients treated with chemotherapy+androgen deprivation therapy (ADT)
by Climent Duran, M.A and Mellado, B and Piulats Rodriguez, J.M and Heras Lopez, L and Juan, M.J and Sáez, M.I and Reig, O and Montesa, A and Suarez, J.F and Hajianfar, R and Ribal, M.J and Rubio, J and Castells, M and Villatoro, R and Sandiego, S and Olmos Hidalgo, D
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text EAU Guidelines on Primary Urethral Carcinoma
by Gakis, Georgios and Witjes, J. Alfred and Compérat, Eva and Cowan, Nigel C and De Santis, Maria and Lebret, Thierry and Ribal, Maria J and Sherif, Amir M and European Association of Urology and Medicinska fakulteten and Urologi och andrologi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 5, pp. 823 - 830
Abstract Context The European Association of Urology (EAU) Guidelines Group on Muscle-Invasive and Metastatic Bladder Cancer prepared these guidelines to... 
Urology | Squamous cell carcinoma | Urethral carcinoma | MRI | Urethral neoplasms | Cytology | Cystoscopy | Radiotherapy | Guidelines | Chemotherapy | Biopsy | Urethra-sparing surgery | Primary | EAU | Penile-preserving surgery | Urethral stricture | BLADDER-CANCER | BACILLUS-CALMETTE-GUERIN | PROGNOSTIC-FACTORS | UROTHELIAL CARCINOMA | PROSTATIC URETHRA | SURGICAL-TREATMENT | RADICAL CYSTECTOMY | SQUAMOUS-CELL CARCINOMA | UROLOGY & NEPHROLOGY | FEMALE URETHRA | Predictive Value of Tests | Prognosis | Humans | Risk Factors | Chemotherapy, Adjuvant - standards | Carcinoma - mortality | Carcinoma - diagnosis | Radiotherapy - standards | Urethral Neoplasms - mortality | Urologic Surgical Procedures - standards | Diagnostic Imaging - standards | Urology - standards | Urethral Neoplasms - diagnosis | Antineoplastic Combined Chemotherapy Protocols - standards | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma - therapy | Diagnostic Techniques, Urological - standards | Urethral Neoplasms - therapy | Neoadjuvant Therapy - standards | Carcinoma | Cancer | Urologi och njurmedicin | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
by Bruins, Harman M and Veskimae, Erik and Hernandez, Virginia and Imamura, Mari and Neuberger, Molly M and Dahm, Philip and Stewart, Fiona and Lam, Thomas B and N’Dow, James and van der Heijden, Antoine G and Compérat, Eva and Cowan, Nigel C and De Santis, Maria and Gakis, Georgios and Lebret, Thierry and Ribal, Maria J and Sherif, Amir and Witjes, J. Alfred and Medicinska fakulteten and Urologi och andrologi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 6, pp. 1065 - 1077
Abstract Context Controversy exists regarding the therapeutic value of lymphadenectomy (LND) in patients undergoing radical cystectomy (RC) for muscle-invasive... 
Urology | or superextended dissection | Lymphadenectomy | Oncologic outcomes | Lymph node dissection | Bladder neoplasms | Standard | Radical cystectomy | extended | Standard extended or superextended dissection | LYMPH-NODE DISSECTION | NUMBER | FREE SURVIVAL | METASTASES | STAGE-SPECIFIC IMPACT | PELVIC LYMPHADENECTOMY | UROLOGY & NEPHROLOGY | Cystectomy | Lymph Node Excision - adverse effects | Neoplasm Invasiveness | Carcinoma, Squamous Cell - pathology | Humans | Urinary Bladder Neoplasms - pathology | Carcinoma, Squamous Cell - surgery | Treatment Outcome | Lymph Node Excision - methods | Urinary Bladder Neoplasms - surgery | Bladder cancer | Patient outcomes | Clinical Medicine | Urologi och njurmedicin | bladder neoplasms | Medical and Health Sciences | Medicin och hälsovetenskap | oncologic outcomes | radical cystectomy | lymph node dissection | Klinisk medicin | Urology and Nephrology | standard extended or superextended dissection | lymphadenectomy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A five-gene expression signature to predict progression in T1G3 bladder cancer
by van der Heijden, Antoine G and Mengual, Lourdes and Lozano, Juan J and Ingelmo-Torres, Mercedes and Ribal, Maria J and Fernández, Pedro L and Oosterwijk, Egbert and Schalken, Jack A and Alcaraz, Antonio and Witjes, J. Alfred
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 64, pp. 127 - 136
Abstract Objective The aim of this study was to analyze tumour gene expression profiles of progressive and non-progressive T1G3 bladder cancer (BC) patients to... 
Hematology, Oncology and Palliative Medicine | Biomarkers | Prognosis | Bladder cancer | Gene expression signature | Progressive disease | HYPERMETHYLATION | ONCOLOGY | TRANSITIONAL-CELL CARCINOMA | GENE-EXPRESSION | RISK | DISABLED-2 | Cell Adhesion Molecules - genetics | Hyaluronoglucosaminidase - metabolism | Humans | Middle Aged | RNA, Messenger - analysis | Male | Carcinoma in Situ - genetics | Urinary Bladder Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Protein-Serine-Threonine Kinases - metabolism | Tumor Suppressor Proteins - metabolism | Annexins - metabolism | Carcinoma in Situ - pathology | Protein-Serine-Threonine Kinases - genetics | Proteoglycans - metabolism | Gene Expression Profiling - methods | Logistic Models | Cell Adhesion Molecules - metabolism | Annexins - genetics | Disease Progression | GPI-Linked Proteins - metabolism | Adaptor Proteins, Signal Transducing - genetics | Aged | Adaptor Proteins, Signal Transducing - metabolism | Hyaluronoglucosaminidase - genetics | Proteoglycans - genetics | GPI-Linked Proteins - genetics | Analysis | Genes | Genetic research | Development and progression | Genetic aspects | Gene expression | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text V58 - Renal cell carcinoma with inferior vena cava thrombus: 3D laparoscopic approach
by Martos Calvo, R and Peri, L and D’Anna, M and Ribal, M.J and Alcaraz, A
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, pp. e2275 - e2275
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text 470 - 10-Year experience of primary cryotherapy for localized prostate cancer treatment: Oncologic and functional outcomes
by Mercader Barrull, C and Musquera, M and Roldán, F.L and Franco, A and Fernández, C and Alcaraz, A and Ribal, M.J
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, pp. e618 - e618
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text PT346 - The role of care pathways in urology: Vision of the European Association of Urology Guidelines Office
by Dimitropoulos, K and Ribal, M.J and van der Velden, A and Plass, K and Shepherd, R and N’Dow, J and Omar, M.I
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, pp. e2136 - e2137
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Renal cell carcinoma with inferior vena cava thrombus: 3D laparoscopic approach
by Martos Calvo, R and Peri, L and D’Anna, M and Ribal, M.J and Alcaraz, A
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, p. e2275
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text 10-Year experience of primary cryotherapy for localized prostate cancer treatment: Oncologic and functional outcomes
by Mercader Barrull, C and Musquera, M and Roldán, F.L and Franco, A and Fernández, C and Alcaraz, A and Ribal, M.J
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, p. e618
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text The role of care pathways in urology: Vision of the European Association of Urology Guidelines Office
by Dimitropoulos, K and Ribal, M.J and van der Velden, A and Plass, K and Shepherd, R and N’Dow, J and Omar, M.I
European Urology Supplements, ISSN 1569-9056, 03/2019, Volume 18, Issue 1, pp. e2136 - e2137
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
by De La Piedra, C and Alcaraz, A and Bellmunt, J and Meseguer, C and Gómez-Caamano, A and Ribal, M.J and Vázquez, F and Anido, U and Samper, P and Esteban, E and Álvarez-Ossorio, J.L and Lara, P.C and San José, L.A and Contreras, J.A and Del Alba, A.G and González-Gragera, B and Tabernero, A.J and González-Enguita, C and Fernández, J.M and García-Escudero, A and Gómez-Veiga, F and Méndez, M.J and Segarra, J and Virizuela, J.A and Carles, J and Lassa, A and Calderero, V and Constela, M and Delgado, D and Mañas, A and Murias, A and Reynes, G and Rodriguez, B and Rubio, G and Sánchez, E and Unda, M and Solsona, E and Martínez-Javaloyas, J.M and Comet-Batlle, J and Quicios, C and Martín-Fernández, M and Mahillo-Fernández, I and Morote, J
British Journal of Cancer, ISSN 0007-0920, 06/2013, Volume 108, Issue 12, pp. 2565 - 2572
Background: Owing to the limited validity of clinical data on the treatment of prostate cancer (PCa) and bone metastases, biochemical markers are a promising... 
skeletal-related events | DIAGNOSIS | prostate cancer | ONCOLOGY | ALKALINE-PHOSPHATASE | MEN | bone metastases | overall survival | bone markers | COMPLICATIONS | disease progression | BREAST | Bone Neoplasms - mortality | Predictive Value of Tests | Prognosis | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Bone Remodeling - physiology | Prostatic Neoplasms - diagnosis | Bone Remodeling - drug effects | Aged, 80 and over | Diphosphonates - therapeutic use | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Prostatic Neoplasms - drug therapy | Biomarkers - metabolism | Prostatic Neoplasms - pathology | Bone Neoplasms - diagnosis | Risk Factors | Biomarkers - analysis | Bone Density Conservation Agents - therapeutic use | Biomarkers - blood | Disease Progression | Prostatic Neoplasms - mortality | Survival Analysis | Aged | Molecular Diagnostics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights